Omega Healthcare Investors, Inc. (OHI) Q1 2026 Earnings Call Transcript
Omega Healthcare Investors is rated Buy, with strong long-term potential and a valuation reflecting elevated risk. OHI delivered a solid Q1, raised 2026 AFFO guidance to $3.19–$3.25 per share, and advanced its SHOP/RIDEA operational pivot. Risks include macro headwinds from the Iran conflict, higher rates, tenant pressures, and increased operational exposure from the SHOP model.
Omega Healthcare Investors (OHI) came out with quarterly funds from operations (FFO) of $0.82 per share, beating the Zacks Consensus Estimate of $0.8 per share. This compares to FFO of $0.75 per share a year ago.
Advisors Capital Management LLC boosted its holdings in Omega Healthcare Investors, Inc. (NYSE: OHI) by 2.0% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 936,433 shares of the real estate investment trust's stock after purchasing an additional 18,342 shares
CPC Advisors LLC acquired a new stake in shares of Omega Healthcare Investors, Inc. (NYSE: OHI) in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 68,790 shares of the real estate investment trust's stock, valued at approximately $3,050,000.
Earned income has a ceiling. But passive income from dividends operates differently: Once established, cash flows in regardless of effort, and the only limit on it is how much you invest in the stocks of companies providing that yield.
Investors aren't putting cash under their mattresses, but they're certainly looking to take some risk off the table. This means rotation out of high-growth technology stocks and looking for value.
Omega Healthcare Investors (OHI) is reiterated as a Buy, supported by strong Q4 results, robust guidance, and potential for dividend increases. OHI's AFFO growth continued, with 2026 guidance implying continued expansion and a solid 5.92% dividend yield at an ~87% payout ratio. Balance sheet strength is underpinned by well-laddered, mostly fixed-rate debt, a new $2.3B credit facility, and recent $600M notes at 5.2%.
Omega Healthcare Investors, Inc. (OHI) Q4 2025 Earnings Call Transcript
Omega Healthcare Investors (OHI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Does Omega Healthcare Investors (OHI) have what it takes to be a top stock pick for momentum investors? Let's find out.
Omega Healthcare Investors offers compelling exposure to the aging population trend with lower operational risk than skilled nursing operators. OHI benefits from high margins, a diversified portfolio, long-term leases, and a solid balance sheet, supporting predictable growth and attractive yields. With a 14.6x FFO valuation and ~6% dividend yield, OHI stands out versus higher-multiple operators and other REITs, combining value and secular tailwinds.